<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "interferon alfa-2b inj PEN">
<dose><value>3</value>
<value>9</value>
<value>36</value>
</dose>
<route><value>SC</value>
</route>
<strength><value>15 million unit/mL</value>
<value>25 million unit/mL</value>
<value>50 million unit/mL</value>
</strength>
<frequency><value>THREE TIMES WEEKLY</value>
<value>DAILY</value>
</frequency>
<instruction></instruction>
<volume><value>1.2 mL</value>
</volume>
<units><value>million IU</value>
</units>
<Population></Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>Chronic Hepatitis C</value>
<value>Hairy Cell Leukemia treatment for 16 to 24 weeks</value>
<value>Chronic myelogenous leukemia (chronic phase)</value>
<value>Aids-related Kaposi&amp;apos;s sarcoma: treatment for 10 to 12 weeks, followed by dose administered 3 times weekly.</value>
<value>Aids-related Kaposi&amp;apos;s sarcoma</value>
</AdditionalNotes>
<BackgroundInformation></BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus></AHSFormularyStatus>
<HighAlert></HighAlert>
</drug>